Cell-Based Manufacturing Technology Increases Antigenic Match of Influenza Vaccine and Results in Improved Effectiveness

MLA

Steven Rockman, et al. “Cell-Based Manufacturing Technology Increases Antigenic Match of Influenza Vaccine and Results in Improved Effectiveness.” Vaccines, vol. 11, no. 1, Dec. 2022, p. 52. EBSCOhost, https://doi.org/10.3390/vaccines11010052.

APA

Steven Rockman, Karen Laurie, Chi Ong, Sankarasubramanian Rajaram, Ian McGovern, Vy Tran, & John Youhanna. (2022). Cell-Based Manufacturing Technology Increases Antigenic Match of Influenza Vaccine and Results in Improved Effectiveness. Vaccines, 11(1), 52. https://doi.org/10.3390/vaccines11010052

Chicago

Steven Rockman, Karen Laurie, Chi Ong, Sankarasubramanian Rajaram, Ian McGovern, Vy Tran, and John Youhanna. 2022. “Cell-Based Manufacturing Technology Increases Antigenic Match of Influenza Vaccine and Results in Improved Effectiveness.” Vaccines 11 (1): 52. doi:10.3390/vaccines11010052.